Basu GD - Search Results

1

Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type.

Gatalica Z, Snyder C, Maney T, Ghazalpour A, Holterman DA, Xiao N, Overberg P, Rose I, Basu GD, Vranic S, Lynch HT, Von Hoff DD, Hamid O. Gatalica Z, et al. Among authors: basu gd. Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2965-70. doi: 10.1158/1055-9965.EPI-14-0654. Epub 2014 Nov 12. Cancer Epidemiol Biomarkers Prev. 2014. PMID: 25392179

2

Molecular profiling of infiltrating urothelial carcinoma of bladder and nonbladder origin.

Millis SZ, Bryant D, Basu G, Bender R, Vranic S, Gatalica Z, Vogelzang NJ. Millis SZ, et al. Clin Genitourin Cancer. 2015 Feb;13(1):e37-49. doi: 10.1016/j.clgc.2014.07.010. Epub 2014 Aug 1. Clin Genitourin Cancer. 2015. PMID: 25178641 Free article.

3

Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases.

Gatalica Z, Millis SZ, Vranic S, Bender R, Basu GD, Voss A, Von Hoff DD. Gatalica Z, et al. Among authors: basu gd. Oncotarget. 2014 Dec 15;5(23):12440-7. doi: 10.18632/oncotarget.2574. Oncotarget. 2014. PMID: 25415047 Free PMC article.

4

Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers.

Wen W, Chen WS, Xiao N, Bender R, Ghazalpour A, Tan Z, Swensen J, Millis SZ, Basu G, Gatalica Z, Press MF. Wen W, et al. J Mol Diagn. 2015 Sep;17(5):487-95. doi: 10.1016/j.jmoldx.2015.04.003. J Mol Diagn. 2015. PMID: 26320869 Free PMC article.

5

Refractory angiosarcoma of the breast with VEGFR2 upregulation successfully treated with sunitinib.

Silva E, Gatalica Z, Vranic S, Basu G, Reddy SK, Voss A. Silva E, et al. Breast J. 2015 Mar-Apr;21(2):205-7. doi: 10.1111/tbj.12380. Epub 2015 Feb 1. Breast J. 2015. PMID: 25639617 No abstract available.

6

Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer.

Azorsa DO, Gonzales IM, Basu GD, Choudhary A, Arora S, Bisanz KM, Kiefer JA, Henderson MC, Trent JM, Von Hoff DD, Mousses S. Azorsa DO, et al. Among authors: basu gd. J Transl Med. 2009 Jun 11;7:43. doi: 10.1186/1479-5876-7-43. J Transl Med. 2009. PMID: 19519883 Free PMC article.

7

Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer.

Pockaj BA, Basu GD, Pathangey LB, Gray RJ, Hernandez JL, Gendler SJ, Mukherjee P. Pockaj BA, et al. Among authors: basu gd. Ann Surg Oncol. 2004 Mar;11(3):328-39. doi: 10.1245/aso.2004.05.027. Ann Surg Oncol. 2004. PMID: 14993030

8

Functional evidence implicating S100P in prostate cancer progression.

Basu GD, Azorsa DO, Kiefer JA, Rojas AM, Tuzmen S, Barrett MT, Trent JM, Kallioniemi O, Mousses S. Basu GD, et al. Int J Cancer. 2008 Jul 15;123(2):330-339. doi: 10.1002/ijc.23447. Int J Cancer. 2008. PMID: 18452169

9

Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification.

Kuuselo R, Savinainen K, Azorsa DO, Basu GD, Karhu R, Tuzmen S, Mousses S, Kallioniemi A. Kuuselo R, et al. Among authors: basu gd. Cancer Res. 2007 Mar 1;67(5):1943-9. doi: 10.1158/0008-5472.CAN-06-3387. Cancer Res. 2007. PMID: 17332321

10

Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition.

Mukherjee P, Basu GD, Tinder TL, Subramani DB, Bradley JM, Arefayene M, Skaar T, De Petris G. Mukherjee P, et al. Among authors: basu gd. J Immunol. 2009 Jan 1;182(1):216-24. J Immunol. 2009. PMID: 19109152 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters